Questions and answers
Q1.Does it matter where I inject?
Not for whether it works. All four weekly products name the same three places (abdomen, thigh, upper arm), treat them as interchangeable, and tell you to rotate between them. None designates a site as more effective, and the pivotal trials allowed all three, so trial-grade results were achieved across the lot. Where site does plausibly matter is in how a dose feels. Absorption from subcutaneous tissue varies modestly by location for peptide drugs generally, which is a reasonable explanation for the widely reported sense that a fresh site hits harder. That is a question of comfort and tolerability, not efficacy. The instruction worth following is to rotate. Any approved site is fine, and no single spot should take repeated hits; the lump question further down explains why.
Source thread ↗PMID 33567185 ↗PMID 35658024 ↗
Q2.Do I need to pinch, and at what angle?
Straight in, at ninety degrees. The pens are built for it. The single-dose devices sit flush to the skin, which lines the needle up perpendicular without you having to judge it. Pinching is the older habit and it still has a place: technique recommendations endorse lifting a fold once a needle passes about 4 mm, and for thinner people, where the point is to avoid landing in muscle rather than fat. If you are lean and injecting the thigh, a pinch is worth doing, because subcutaneous tissue is thinnest there. The sequence that avoids most problems is to pinch if you need to, insert straight, press, and then hold the pen still until the counter or click confirms delivery is finished before you release and withdraw. Pulling out early is the one mistake on this page that does lose a dose.
Source thread ↗PMID 27594187 ↗
Q3.Is bruising normal?
Yes, and it is usually not a technique error. Injection-site reactions including bruising are listed as expected on these labels, and the large injection-technique survey found bleeding and bruising to be common in routine practice, rising with longer needles and reused ones. A bruise means the needle clipped a small capillary going in or coming out. That happens, and it happens more readily if you are on an anticoagulant, take aspirin, or use fish oil or high-dose vitamin E, so do not read it as doing something wrong. A bruise that appears, changes color over a week and fades is ordinary. One that is large, painful, spreading or warm is not, and should go to a clinician. In the meantime, use the other side for the next dose and let the area recover.
Source thread ↗PMID 27594186 ↗
Q4.There was blood. Did I lose the dose?
No, and do not redose. A bead of blood at the puncture is common and the labels say so directly: hold clean gauze or cotton on the spot, without rubbing it. The device, not the skin, tells you the dose was delivered. If the counter reached zero or the clicks finished before you withdrew, the drug is in the subcutaneous tissue, and a nicked capillary on the way out does not pull it back. None of these labels recommend repeating a dose because of bleeding, and taking a second one because of a drop of blood is a real overdose risk in exchange for an imagined lost dose. If you bleed at every single injection, look at your rotation first. Usually it means one site is being used too often, and rotating away from it fixes it.
Source thread ↗PMID 27594186 ↗
Q5.Is the needle long enough if I carry more weight?
Yes. The instinct that a bigger body needs a longer needle is one the evidence contradicts. A randomized trial of a 4 mm pen needle in adults with obesity and diabetes found it worked just as well as the longer ones, hurt less and leaked no more often, right across a wide BMI range including above 40. That is the point of a short needle: subcutaneous fat sits directly under the skin at any size, so depth is not the limiting factor, while a longer needle raises the odds of overshooting into muscle. Technique recommendations accordingly make short needles the default for adults regardless of body size, with a pinched fold added for very thin people rather than a longer needle for larger ones. All four pens use short, fine, fixed-length needles designed on that basis.
Source thread ↗PMID 25662503 ↗PMID 27594187 ↗
Q6.Why did this week's shot sting more?
Almost always temperature, site or a reused needle. The injection-technique survey identified cold injectate, reused needles and certain sites as the biggest patient-reported drivers of pain. Cold is the one people most often fix by accident. Fluid well below skin temperature stings going in, which is why standing the pen out for half an hour or so beforehand makes such a noticeable difference. Site biology explains most of the rest: the thigh and upper arm are more densely innervated than the lower belly, and reliably sting more for many people. Do not speed the warming up with a microwave, a hot tap or a radiator. Heat degrades the peptide, and you cannot see that it has. A fresh needle, an abdominal site and a pen that is not straight out of the fridge are the three levers worth pulling.
Source thread ↗PMID 27594186 ↗
Q7.How long can a pen stay out of the fridge?
Briefly. All four labels permit a period out of refrigeration, but the permitted window and maximum temperature are not the same across these products. This is the one place on this page we deliberately do not print a number, because quoting one drug's window at someone holding another drug's pen is exactly the error worth avoiding. Read the leaflet in your own box for the cumulative out-of-fridge limit, and discard any pen that has exceeded it. Note the word cumulative: the clock does not reset when you put it back. Within your product's limit, letting the pen come up to room temperature before injecting is the single cheapest thing you can do about stinging, and it lines up with cold injectate being a leading reported cause of pain. Never warm it artificially.
Source thread ↗PMID 27594186 ↗
Q8.Do I really need an alcohol swab?
Follow the label and use one. The evidence behind the rule is softer than most people assume, though, so a missed swab is no reason to panic. Every one of these products instructs you to wash your hands and clean the site, with an alcohol wipe as the usual method. The technique recommendations note that someone injecting into visibly clean skin at home, with washed hands, is not strictly required to prep with alcohol first. No label endorses skipping it, so the safe default is to keep doing it. The part people get wrong matters more than the swab itself: let it dry off entirely before the needle goes near you. Injecting through wet alcohol stings considerably, and that sting is routinely blamed on the drug.
Source thread ↗PMID 27594187 ↗
Q9.What is the hard lump where I always inject?
Most likely lipohypertrophy, a thickening of fat tissue where repeated injections have gone into the same place. Among the things that go wrong with long-term subcutaneous injection it is both the commonest and the most preventable, and failure to rotate is its strongest predictor: a prevalence study of 430 insulin-injecting adults found it in 64.4%. It matters for more than appearance. Absorption from a lipohypertrophic area becomes unpredictable (sometimes slower, sometimes faster), so the dose you take stops reliably being the dose you get. For a drug titrated by response, that is a serious problem. Moving away from it helps. In a randomized study of insulin users with these lumps, the group given intensive injection-technique training, including rotation and a short needle, needed just over 5 units less insulin a day within three to six months. Rotate with every injection and leave a good centimeter or more between punctures. Show it to your prescriber, and never inject into hard, inflamed or scarred tissue.
Source thread ↗PMID 23886784 ↗PMID 27594187 ↗PMID 29058477 ↗
Q10.Why does a new site feel like a dose increase?
Because it may effectively be one, and the explanation is the lump above. If a site has taken months of injections, it may be absorbing less reliably than you assume. An affected patch absorbs less reliably than intact tissue, and in the randomized lipohypertrophy study, insulin users trained to inject away from such patches needed less insulin within months. That evidence comes from daily insulin, but a weekly GLP-1 goes into the same fat layer, so the same problem is likely. So the first injection into fresh tissue can deliver a fuller, faster peak than you have been getting. That arrives as a week of sharper appetite suppression and stronger nausea, and feels exactly like a dose step. It is usually self-limiting over a week or two. The practical lesson is about timing: move off an overused site while you are steady on a dose, not in the same week you titrate up, or you will have no way to tell which change caused what.
Source thread ↗PMID 29058477 ↗PMID 27594187 ↗
Questions are paraphrased from public forum threads and linked to their source where one was recorded. Answers summarize published trial data and FDA labeling. This is not medical advice, and no part of it replaces the judgment of whoever prescribes for you.